$10.41
-0.44 (-4.06%)
VITL News2 articles
Stellantis Unveils $70B Strategy to Revitalize Jeep, Ram, and European Brands
Stellantis launched a €60 billion five-year plan to boost profits, focusing on key brands like Jeep and Ram, with a goal of 25% revenue growth in North America.
Bayer's $2.45B Perfuse Buy Aims to Revitalize Eye Drug Pipeline
Bayer acquires Perfuse Therapeutics for up to $2.45 billion to secure Phase II eye drug PER-001, aiming to bolster its ophthalmology unit as Eylea sales slip.